Skip to main content
Log in

26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice

  • Genotoxicity and Carcinogenicity
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

This study examined the carcinogenic potential of di-isodecyl phthalate (DIDP) in rasH2 mice. DIDP was administered to 15 rasH2 mice/gender/group at dietary levels of 0, 0.1, 0.33, or 1% and 15 wild-type mice/gender/group at dietary levels of 0 and 1% for 26 weeks. Non-neoplastic changes were observed in the liver (parenchymal inflammation, fatty changes, diffuse hepatocyte hypertrophy with eosinophilic granules and focal necrosis) and kidneys (tubular basophilia and tubular hyperplasia) after administration of DIDP in the rasH2 and wild-type mice. In the neoplastic lesions, there were a higher number of hepatocellular adenomas in the male rasH2 mice receiving 1% DIDP, compared with the findings in the liver of control rasH2 mice or wild-type mice. The incidence of hepatocellular adenomas in the 0.1, 0.33, and 1% DIDP exposed rasH2 mice was 7% (1/15), 7% (1/15), and 33% (5/15), respectively. This study adds a set of results for an additional test chemical for the performance of the rasH2 short-term transgenic model to the existing database of 3 compounds (WY-14643, DEHP, and clofibrate) tested in the ILSI/HESI ACT project.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

DIDP:

Di-isodecyl phthalate

MNU:

N-Methyl-N-nitrosourea

DEHP:

Di(2-ethylhexyl)phthalate

DINP:

Di-isononyl phthalate

CIEA:

Central Institute for Experimental Animals

ILSI-HESI:

International Life Sciences Institute/Health and Environmental Science Institute

Tg:

Transgenic

WT:

Wild-type

ICH:

International Conference on Harmonization

MTD:

Maximum Tolerated Dose

References

  • Alden C, Smith P, Morton D (2002) Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development. Toxicol Pathol 30:135–138

    Article  PubMed  Google Scholar 

  • Cho WS, Han BS, Ahn B, Nam KT, Choi M, Oh SY, Kim SH, Jeong J, Jang DD (2008) Peroxisome proliferator di-isodecyl phthalate has no carcinogenic potential in Fischer 344 rats. Toxicol Lett 178:110–116

    Article  CAS  PubMed  Google Scholar 

  • Cohen SM, Robinson D, MacDonald J (2001) Alternative models for carcinogenicity testing. Toxicol Sci 64:14–19

    CAS  PubMed  Google Scholar 

  • David RM, Moore MR, Cifone MA, Finney DC, Guest D (1999) Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci 50:195–205

    Article  CAS  PubMed  Google Scholar 

  • Giam CS, Atlas E, Powers MA Jr, Leonard JE (1984) Phthalic acid esters. In: Hutzinger O (ed) Handbook of environmental chemistry — Anthropogenic compounds vol. 3. Springer, Berlin, pp 67–142

    Google Scholar 

  • Graham PR (1973) Phthalate ester plasticizers–why and how they are used. Environ Health Perspect 3:3–12

    Article  CAS  PubMed  Google Scholar 

  • ICH (1997) ICH harmonized tripartite guideline Testing for carcinogenicity of pharmaceuticals

  • Ito Y, Yamanoshita O, Kurata Y, Kamijima M, Aoyama T, Nakajima T (2007) Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets. Arch Toxicol 81(3):219–226

    Article  CAS  PubMed  Google Scholar 

  • James NH, Soames AR, Roberts RA (1998) Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1, 4-dichlorobenzene (DCB). Arch Toxicol 172(12):784–790

    Article  Google Scholar 

  • Kaufmann W, Deckardt K, McKee RH, Butala JH, Bahnemann R (2002) Tumor induction in mouse liver: di-isononyl phthalate acts via peroxisome proliferation. Regul Toxicol Pharmacol 36:175–183

    Article  CAS  PubMed  Google Scholar 

  • Kim CK, Han BS, Oh JH, Cho W-S, Park KD, Choi M, Cho MJ, Oh SY, Kim SJ, Jeong JY, Kim SH, Jang DD (2006) Four-week repeated-dose toxicity study of di-isodecyl phthalate (DIDP) in rasH2 wild type mice. Lab Animal Res 22:289–293

    Google Scholar 

  • Kim HS, Ishizaka M, Kazusaka A, Fujita S (2007) Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells. Arch Toxicol 81(1):27–33

    Article  CAS  PubMed  Google Scholar 

  • Kluwe WM, Haseman JK, Douglas JF, Huff JE (1982) The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J Toxicol Environ Health 10:797–815

    Article  CAS  PubMed  Google Scholar 

  • Lington AW, Bird MG, Plutnick RT, Stubblefield WA, Scala RA (1997) Chronic toxicity and carcinogenic evaluation of diisononyl phthalate in rats. Fundam Appl Toxicol 36:79–89

    Article  CAS  PubMed  Google Scholar 

  • Marsman DS, Cattley RC, Conway JG, Popp JA (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643) in rats. Cancer Res 48:6739–6744

    CAS  PubMed  Google Scholar 

  • Mitsumori K, Loizumi H, Nomura T, Yamamoto S (1998) Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 26:520–531

    Article  CAS  PubMed  Google Scholar 

  • Morton D, Alden C, Roth AJ, Usui T (2002) The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30:139–146

    Article  PubMed  Google Scholar 

  • Nesfield SR, Clarke CJ, Hoivik DJ, Miller RT, Allen JS, Selinger K, Santostefano MJ (2005) Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse. Int J Toxicol 24:301–311

    Article  CAS  PubMed  Google Scholar 

  • Peters JM, Cattley RC, Gonzalez FJ (1997) Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14, 643. Carcinogenesis 18:2029–2033

    Article  CAS  PubMed  Google Scholar 

  • Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, Katsuki M (1990) Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5:1195–11200

    CAS  PubMed  Google Scholar 

  • Takaoka M, Sehata S, Maejima T, Imai T, Torii M, Satoh H, Toyosawa K, Tanakamaru Z-Y, Adachi T, Hisada S, Ueda M, Ogasawara H, Matsumoto M, Kobayashi K, Mutai M, Usui T (2003) Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice. Toxicol Pathol 31:191–199

    CAS  PubMed  Google Scholar 

  • Tamaoki N (2001) The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol 29 Suppl: 81–89

    Google Scholar 

  • Toyosawa K, Okimoto K, Kobayashi I, Kijima K, Kikawa E, Kohchi M, Koujitani T, Tanaka K, Matsuoka N (2001) Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. Toxicol Pathol 29:458–466

    Article  CAS  PubMed  Google Scholar 

  • Usui T, Mutai M, Hisada S, Takoaka M, Soper K, McCullough B, Alden C (2001) CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29(Suppl):90–108

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Agrawal S, Cook TJ, Knipp GT (2007) Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure. Arch Toxicol 81(1):57–62

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Professor Byeongwoo Ahn (Veterinary Pathologist, Chungbuk National University) for performing the pathology peer review. This study was supported by a grant from the Korea National Toxicology Program from the National Institute of Toxicological Research of Korea Food and Drug Administration.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Beom Seok Han or Woo-Chan Son.

Additional information

W.-S. Cho and J. Jeong contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, WS., Jeong, J., Choi, M. et al. 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice. Arch Toxicol 85, 59–66 (2011). https://doi.org/10.1007/s00204-010-0536-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-010-0536-6

Keywords

Navigation